New Name?BTH owning Nash Pharma. Sort of like adding another story onto the house.
Seems the Bullrun Team is adding another company under the BTH umbrella.
NASH are onto something big with treatment of NASH (Non-Alcoholic Steatohepatitis), Chronic Kindney Disease (CKD) and IBD.
The connection is the medical application. The diagnostic tool and treatment of diseases NASH are focused on, the BTH tool will be able to detect. That is the goal. A lot more work to do, but the concept is viable with this team.
I like this. Leads me to believe the advancement by the YOST team on FAIM technology used for Cannabix has reached a place where some attention can return to BTH and their growth.
If this is the case, great news pending for Cannabix, the device is very close to reaching Canadian Government standards. And a surge in sp for BTH as increased volume comes to BTH through BLO.